Title:Stem Cells and Tissue Engineering in Medical Practice: Ethical and Regulatory Policies
VOLUME: 20 ISSUE: 4
Author(s):Rakesh Sharma*
Affiliation:Iinovations and Solutions Inc. FSU Tallahassee AMET University Global
Keywords:Pluripotent stem cells, stem cell medical practice, tissue engineering, stem cell therapy, stem cell legal status, government
guidelines, regulatory polices.
Abstract:Stem Cell Research and Tissue Engineering, in present time, have emerged as a legalized
and regulated stem cell treatment option globally, but scientifically, their success is unestablished.
Novel stem cell-based therapies have evolved as innovative and routine clinical solutions by commercial
companies and hospitals across the world. Such rampant spread of stem cell clinics throughout
UK, US, Europe and Asia reflect the public encouragement of benefits to incurable diseases. However,
ever growing stem cell therapy developments need constant dogwatch and careful policy making
by government regulatory bodies for prompt action in case of any untoward public concern. Therefore,
researchers and physicians must keep themselves abreast of current knowledge on stem cells, tissue
engineering devices in treatment and its safe legal limits. With this aim, stem cell scienctific developments,
treatment options and legal scenario are introduced here to beginner or actively inolved scientists
and physicians. Introduction to stem cell therapy will provide basic information to beginner researchers
and practice physicians on engineered stem cell research concepts and present stem cell
therapy federal regulations in different North American, European and Asian countries. FDA, CDC,
EU, ICMR government policies in different countries include information on the current legal position,
ethical policies, regulatory oversight and relevant laws.
